You are viewing the site in preview mode
Skip to main content
| |
Total
|
NFTG
|
HFTG
|
P
|
|---|
|
n = 472
|
n = 322
|
n = 150
|
|---|
|
Age
|
44 ± 13
|
43 ± 14
|
47 ± 11
|
0.176
|
|
Sex(male/female)
|
224/248
|
133/189
|
91/59
|
0.084
|
|
BMI
|
25.93 ± 4.05
|
24.94 ± 3.76
|
28.06 ± 3.85**
|
< 0.001
|
|
FBG
|
5.41 (5.07,5.87)
|
5.32 (5.00,5.73)
|
5.60 (5.34,6.31) **
|
< 0.001
|
|
FINS
|
10.65 (7.35,15.24)
|
9.55 (6.59,12.72)
|
13.85 (10.20,18.83) **
|
< 0.001
|
|
HOMA-IR
|
2.60 (1.70,3.82)
|
2.24 (1.52,3.11)
|
3.70 (2.60,5.07) **
|
< 0.001
|
|
TC
|
4.72 ± 1.01
|
4.50 ± 0.93
|
5.19 ± 1.02**
|
< 0.001
|
|
TG
|
1.66 ± 1.31
|
1.04 ± 0.32
|
2.98 ± 1.62**
|
< 0.001
|
|
HDL-C
|
1.25 ± 0.28
|
1.30 ± 0.28
|
1.14 ± 0.24**
|
< 0.001
|
|
LDL-C
|
2.98 ± 0.73
|
2.82 ± 0.69
|
3.32 ± 0.70**
|
< 0.001
|
|
NAFLD
|
155 (32.8%)
|
64 (19.9%)
|
91 (60.7%) **
|
< 0.001
|
|
Non-NAFLD
|
317 (67.2%)
|
258 (80.1%)
|
59 (39.3%)
|
< 0.001
|
- Data are mean ± standard deviation, median (interquartile range), or number (percentage)
- Abbreviations NFTG normal fasting triglyceride group, HFTG High fasting triglyceride group, BMI body mass index, FBG fasting blood glucose, FINS fasting plasma insulin concentration, HOMA-IR homeostasis model assessment of insulin resistance, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein-cholesterol, LDL-C low-density lipoprotein-cholesterol, NAFLD nonalcoholic fatty liver disease
- * P < 0.05, compared with the NFT group. ** P < 0.01, compared with the NFT group
